Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Zotiraciclib citrate by Beijing zhikangbo Medical Oncology Research for Glioblastoma Multiforme (GBM): Likelihood of Approval
Zotiraciclib citrate is under clinical development by Beijing zhikangbo Medical Oncology Research and currently in Phase II for Glioblastoma Multiforme...
Data Insights
Zotiraciclib citrate by Beijing zhikangbo Medical Oncology Research for High-Grade Glioma: Likelihood of Approval
Zotiraciclib citrate is under clinical development by Beijing zhikangbo Medical Oncology Research and currently in Phase II for High-Grade Glioma....